Tag: Drug delivery systems

The World Health Organization estimates that approximately 50% of people with chronic diseases do not take their medications as prescribed [1.5.2, 1.5.4]. This challenge of non-adherence is a primary reason why medical science has explored **how do slow-release injections work** to provide a more reliable solution.

An estimated 1 in 3 people have difficulty swallowing pills, a condition known as dysphagia, which can lead to missed doses and ineffective treatment. Fortunately, a variety of innovative and accessible options exist for those asking, 'What can I use instead of pills?' to ensure they can manage their health effectively and comfortably.

The acronym AFS can refer to multiple distinct technologies and services within the pharmaceutical industry, and the interpretation depends heavily on the context. While one major application, Atomic Fluorescence Spectroscopy (AFS), is a key analytical method used for detecting trace metal contaminants in drugs, the term also encompasses Advanced Formulation Services and Automated Formulation Systems that drive innovation in drug delivery and manufacturing.

For decades, the idea of oral peptides seemed impossible, as their bioavailability can be less than 2% for unmodified versions. However, thanks to scientific breakthroughs in delivery technology, the landscape is changing, and the question 'Do oral peptides work?' is now answered with a nuanced 'it depends'.